{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06019000",
            "orgStudyIdInfo": {
                "id": "CYR-064-01"
            },
            "organization": {
                "fullName": "Cyrano Therapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study of CYR-064 Versus Placebo in Patients.",
            "officialTitle": "A Randomized, Double-Blinded, Placebo-Controlled Trial to Determine The Safety and Efficacy of CYR-064",
            "therapeuticArea": [
                "Other"
            ],
            "study": "study-of-cyr-versus-placebo-in-patients"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-12",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-09-26",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-01-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-05-11",
            "studyFirstSubmitQcDate": "2023-08-24",
            "studyFirstPostDateStruct": {
                "date": "2023-08-31",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-30",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Cyrano Therapeutics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "Randomized, double-blinded, placebo-controlled trial to determine the safety and efficacy of CYR-064.",
            "detailedDescription": "The purpose of this study is to determine the safety and effectiveness of CYR-064 in a randomized, double-blinded, placebo-controlled trial to determine the safety and efficacy of CYR064.\n\nThe study will take approximately 32 weeks which will include a 4-week screening period to evaluate if participants are right for the Study, followed by a 24-week Treatment Period, and a 1 week follow up after participants have completed the Study. About 150 subjects will participate in this study in about 25 research sites in the United States."
        },
        "conditionsModule": {
            "conditions": [
                "Hyposmia"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "The study treatment of CYR-064 is administered for a 24-week Treatment Period. Patients who meet all study criteria and have consented to participation will be randomized (1:1:1) to three parallel study arms, with two different dose strengths and a placebo group over 24 weeks.\n\nCYR-064 dose 1 CYR-064 dose 2 Placebo",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "maskingDescription": "There will be a placebo match and blinded randomization.",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 150,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "CYR-064 dose 1",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Treatment with nasal solution of CYR-064 twice a day for 24 weeks. CYR-064 will be self-administered by patients.",
                    "interventionNames": [
                        "Combination Product: CYR-064"
                    ]
                },
                {
                    "label": "CYR-064 dose 2",
                    "type": "EXPERIMENTAL",
                    "description": "Treatment with nasal solution of CYR-064 twice a day for 24 weeks. CYR-064 will be self-administered by patients.",
                    "interventionNames": [
                        "Combination Product: CYR-064"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Treatment with Placebo nasal solution for 24 weeks. CYR-064 will be self-administered by patients.",
                    "interventionNames": [
                        "Combination Product: CYR-064"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "COMBINATION_PRODUCT",
                    "name": "CYR-064",
                    "description": "CYR-064 is a nasal solution.",
                    "armGroupLabels": [
                        "CYR-064 dose 1",
                        "CYR-064 dose 2",
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Primary Outcome - Safety and Tolerability",
                    "description": "The count and percentage of patients reporting AEs, SAEs, and SUSARs will be summarized overall, by System Organ Class, Preferred Term within the System Organ Class, maximum severity, and relationship to study drug. All other safety parameters, including clinical laboratory values through blood draws, will be summarized using descriptive statistics for continuous variables and counts and percentages for categorical variables. All changes in nasal mucosal appearance will be noted.",
                    "timeFrame": "Approximately 32 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Secondary Outcome-improvement on NRS-11 Smell-PRO",
                    "description": "Improvement in patient reported NRS-11 Smell-PRO (scale of 0-10) in CYR-064 low dose and high dose groups as compared with placebo from Baseline to Week 24.",
                    "timeFrame": "Approximately 24 weeks"
                },
                {
                    "measure": "Secondary Outcome-improvement on NRS-11 Taste-PRO",
                    "description": "Improvement in patient reported NRS-11 Taste-PRO (scale of 0-10) in CYR-064 low dose and high dose groups as compared with placebo from Baseline to Week 24.",
                    "timeFrame": "Approximately 24 weeks"
                },
                {
                    "measure": "Secondary Outcome-Mean Change in NRS-11 Smell-PRO",
                    "description": "Mean Change in NRS-11 Smell-PRO from Baseline to Week 24 between CYR-064 low and high dose and placebo from Baseline to Week 24",
                    "timeFrame": "Approximately 24 weeks"
                },
                {
                    "measure": "Secondary Outcome-Mean Change in NRS-11 Taste-PRO",
                    "description": "Mean Change in NRS-11 Taste-PRO from Baseline to Week 24 between CYR-064 low and high dose and placebo from Baseline to Week 2",
                    "timeFrame": "Approximately 24 weeks"
                },
                {
                    "measure": "Change in Visual Rating Scale (VRS) scores",
                    "description": "Change in Visual Rating Scale (VRS) scores in CYR-064 low dose and high dose groups as compared with placebo from Baseline to Week 24.\n\n* VRS high dose versus placebo\n* VRS low dose versus placebo\n* VRS low and high dose combined versus placebo",
                    "timeFrame": "Approximately 24 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Able to provide written informed consent.\n* Male or female 18-65 years of age.\n* Endoscopy of the nasal cavity showing no structural or pathologic issues leading to hyposmia (nasal polyps, sinusitis, infection, etc.) that in the opinion of the Investigator, believes would hinder the delivery of study drug to the olfactory receptors.\n* CT scan of the nasal cavity after the onset of hyposmia (within prior 2 years) prior to Baseline showing no structural or pathologic issue leading to hyposmia that in the opinion of the Investigator, believes would hinder the delivery of study drug to the olfactory receptors.\n* Willing and able to self-administer the study drug, follow the study drug administration instructions, comply with study procedures, and participate in the scheduled study visits specified in this protocol.\n\nExclusion Criteria:\n\n* History of traumatic brain injury, Parkinson's disease, early dementia, Alzheimer's disease, or any other condition in which hyposmia is not expected to improve in the opinion of the Investigator, such as history of congenital or idiopathic hyposmia or a surgical procedure that led to hyposmia.\n* History of surgery that led to hyposmia.\n* Concomitant Medical Conditions\n* Current symptoms or signs of an acute respiratory viral illness at Screening or Baseline.\n* Chronic viral infection or immunodeficiency condition (e.g., medical history of human immunodeficiency virus) based on medical records.\n* Any active malignancy.\n* Any concomitant medical condition that in the opinion of the Investigator, compromises patient safety or compliance with the study protocol or collected data.\n* History of moderate to severe Substance Use Disorder within the past 3 years as assessed by the Investigator.\n* History of persistent chronic sinusitis without polyps or chronic sinusitis with polyps.\n* Use or planned use of tobacco or nicotine-containing products, including smoking, smokeless tobacco, e-cigarettes, or nicotine replacement products within 3 months prior to Screening through EOS.\n* Unwilling or unable to discontinue current or planned use of over the counter or prescription medication administered intranasally, with the exception of nasal saline.\n* Use or planned use of another investigational drug within 4 weeks prior to Screening through Follow-Up.\n* Receiving any concomitant medication/therapy that would, in the opinion of the Investigator, compromise patient safety or compliance with the study protocol or collected data.\n* General Exclusions Any female who is pregnant, planning to become pregnant during the study, or who is lactating.\n\nVulnerable patients. Any condition or abnormality (including clinical laboratory, physical examination, or vital sign abnormalities), current or past, that, in the opinion of the Investigator, would compromise the efficacy evaluation, safety of the patient, or would interfere with or complicate study procedures or assessments.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Rick Geoffrion",
                    "role": "CONTACT",
                    "phone": "9258226461",
                    "email": "Rick@cyranotherapeutics.com"
                },
                {
                    "name": "Krista Geoffrion",
                    "role": "CONTACT",
                    "email": "Krista@cyranotherapeutics.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Mas Takashima, MD",
                    "affiliation": "The Methodist Hospital Research Institute",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Colorado ENT & Allergy",
                    "status": "RECRUITING",
                    "city": "Colorado Springs",
                    "state": "Colorado",
                    "zip": "80923",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Monica Davis",
                            "role": "CONTACT",
                            "phone": "719-867-7804",
                            "email": "mdavis@coloradoent.com"
                        },
                        {
                            "name": "Sierra Archuleta",
                            "role": "CONTACT",
                            "phone": "719-867-7804",
                            "email": "SArchuleta@coloradoent.com"
                        },
                        {
                            "name": "Bryan Davis, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.83388,
                        "lon": -104.82136
                    }
                },
                {
                    "facility": "ENTAAFL",
                    "status": "RECRUITING",
                    "city": "Boca Raton",
                    "state": "Florida",
                    "zip": "33487",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sandy Dibattista",
                            "role": "CONTACT",
                            "phone": "561-939-0186",
                            "email": "oadibattista@entaaf.com"
                        },
                        {
                            "role": "CONTACT",
                            "phone": "561-414-3816"
                        },
                        {
                            "name": "Nathan Nachlas, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.3669,
                        "lon": -80.13033
                    }
                },
                {
                    "facility": "ENTAAFL",
                    "status": "RECRUITING",
                    "city": "Plantation",
                    "state": "Florida",
                    "zip": "33324",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lindsay Dwyer",
                            "role": "CONTACT",
                            "phone": "954-476-0400",
                            "email": "ldwyer@entaaf.com"
                        },
                        {
                            "name": "Jon Rosenthal, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.13421,
                        "lon": -80.23184
                    }
                },
                {
                    "facility": "ENTAAFL",
                    "status": "RECRUITING",
                    "city": "Port Saint Lucie",
                    "state": "Florida",
                    "zip": "34952",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Laurie Robinson",
                            "role": "CONTACT",
                            "phone": "772-777-2124",
                            "email": "lrobinson@entaaf.com"
                        },
                        {
                            "role": "CONTACT",
                            "phone": "772-398-9911",
                            "phoneExt": "119"
                        },
                        {
                            "name": "John Lanza, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 27.29393,
                        "lon": -80.35033
                    }
                },
                {
                    "facility": "Rush University Medical Center",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60612",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mahendra Shah",
                            "role": "CONTACT",
                            "phone": "312-942-9967",
                            "email": "mahendrakumar_shah@rush.edu"
                        },
                        {
                            "name": "Pete Batra, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "KU Medical Center-University of Kansas",
                    "status": "RECRUITING",
                    "city": "Kansas City",
                    "state": "Kansas",
                    "zip": "66160-8500",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Bryan Humphrey",
                            "role": "CONTACT",
                            "phone": "913-588-3759",
                            "email": "bhumphrey@kumc.edu"
                        },
                        {
                            "name": "Kelsey Murray",
                            "role": "CONTACT",
                            "email": "kmurray@kumc.edu"
                        },
                        {
                            "name": "Jennifer Villwock, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.11417,
                        "lon": -94.62746
                    }
                },
                {
                    "facility": "Kentuckian ENT",
                    "status": "RECRUITING",
                    "city": "Louisville",
                    "state": "Kentucky",
                    "zip": "40205",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kathleen Sheeley",
                            "role": "CONTACT",
                            "phone": "502-894-8441",
                            "phoneExt": "225",
                            "email": "ksheeley@kentuckianaent.com"
                        },
                        {
                            "name": "Thomas Higgins, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.25424,
                        "lon": -85.75941
                    }
                },
                {
                    "facility": "Advanced ENT and Allergy",
                    "status": "RECRUITING",
                    "city": "Louisville",
                    "state": "Kentucky",
                    "zip": "40220",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rhonda Dase",
                            "role": "CONTACT",
                            "phone": "502-893-0159",
                            "phoneExt": "1184",
                            "email": "rdase@advancedentandallergy.com"
                        },
                        {
                            "name": "Amy Ingram, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.25424,
                        "lon": -85.75941
                    }
                },
                {
                    "facility": "Tandem Clinical Research",
                    "status": "RECRUITING",
                    "city": "Marrero",
                    "state": "Louisiana",
                    "zip": "70072",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Will Bryan",
                            "role": "CONTACT",
                            "phone": "504-934-8424",
                            "email": "wbryan@tandemclinicalresearch.com"
                        },
                        {
                            "name": "Nikki LaCroix",
                            "role": "CONTACT",
                            "phone": "504-934-8424",
                            "email": "nlacroix@tandemclinicalresearch.com"
                        },
                        {
                            "name": "Adil Fatakia, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.89937,
                        "lon": -90.10035
                    }
                },
                {
                    "facility": "Centers for Advanced ENT",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21204",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Shayne Litz",
                            "role": "CONTACT",
                            "phone": "410-821-5151",
                            "email": "slitz@cadentcare.com"
                        },
                        {
                            "name": "Douglas Reh, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Specialty Physician Associates",
                    "status": "RECRUITING",
                    "city": "Bethlehem",
                    "state": "Pennsylvania",
                    "zip": "18017",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "David Campbell",
                            "role": "CONTACT",
                            "phone": "610-866-5555",
                            "email": "dcambell@specialtyphysicianassociates.com"
                        },
                        {
                            "name": "David Yen, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.62593,
                        "lon": -75.37046
                    }
                },
                {
                    "facility": "Medical University of South Carolina-MUSC",
                    "status": "RECRUITING",
                    "city": "Charleston",
                    "state": "South Carolina",
                    "zip": "29425",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Alejandro Marrero-Gonzalez",
                            "role": "CONTACT",
                            "phone": "843-792-1356",
                            "email": "marrerog@musc.edu"
                        },
                        {
                            "name": "Rodney Schlosser, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Shaun Nguyen, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.77657,
                        "lon": -79.93092
                    }
                },
                {
                    "facility": "Charleston ENT and Allergy",
                    "status": "RECRUITING",
                    "city": "North Charleston",
                    "state": "South Carolina",
                    "zip": "29406",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Simone Ansley",
                            "role": "CONTACT",
                            "phone": "843-654-8884",
                            "email": "sansley@charlestonent.com"
                        },
                        {
                            "name": "Amanda Jones",
                            "role": "CONTACT",
                            "phone": "843-654-8884",
                            "email": "ajones@charlestonent.com"
                        },
                        {
                            "name": "Thomas Murphy, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.85462,
                        "lon": -79.97481
                    }
                },
                {
                    "facility": "Houston Methodist",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Tariq Syed",
                            "role": "CONTACT",
                            "phone": "346-238-6466",
                            "email": "Tasyed@houstonmethodist.org"
                        },
                        {
                            "name": "Mas Takashima, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Ear Nose Throat & Allergy Associates",
                    "status": "RECRUITING",
                    "city": "Puyallup",
                    "state": "Washington",
                    "zip": "98374",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Anne Davis",
                            "role": "CONTACT",
                            "phone": "253-770-9000",
                            "email": "adavis16@icloud.com"
                        },
                        {
                            "name": "Greg Davis, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.18538,
                        "lon": -122.2929
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "type": "BACKGROUND",
                    "citation": "Henkin RI. Growth Factors in Olfaction. In: Preedy VR, editor. Handbook of Growth and Growth Monitoring in Health and Disease. New York, NY: Springer New York; 2012. p. 1417-36."
                },
                {
                    "type": "BACKGROUND",
                    "citation": "Henkin RI, Abdelmeguid M. Improved Smell and Taste Dysfunction with Intranasal Theophylline. Am J Otolaryngol Head Neck Surg. 2019;2(9):1070."
                },
                {
                    "pmid": "23731850",
                    "type": "RESULT",
                    "citation": "Henkin RI, Levy LM, Fordyce A. Taste and smell function in chronic disease: a review of clinical and biochemical evaluations of taste and smell dysfunction in over 5000 patients at The Taste and Smell Clinic in Washington, DC. Am J Otolaryngol. 2013 Sep-Oct;34(5):477-89. doi: 10.1016/j.amjoto.2013.04.006. Epub 2013 Jun 2."
                },
                {
                    "pmid": "22377744",
                    "type": "RESULT",
                    "citation": "Henkin RI. Comparative monitoring of oral theophylline treatment in blood serum, saliva, and nasal mucus. Ther Drug Monit. 2012 Apr;34(2):217-21. doi: 10.1097/FTD.0b013e3182492a20."
                },
                {
                    "pmid": "27923495",
                    "type": "RESULT",
                    "citation": "Henkin RI, Hosein S, Stateman WA, Knoppel AB, Abdelmeguid M. Improved smell function with increased nasal mucus sonic hedgehog in hyposmic patients after treatment with oral theophylline. Am J Otolaryngol. 2017 Mar-Apr;38(2):143-147. doi: 10.1016/j.amjoto.2016.11.010. Epub 2016 Nov 23."
                },
                {
                    "pmid": "23165381",
                    "type": "RESULT",
                    "citation": "Henkin RI, Schultz M, Minnick-Poppe L. Intranasal theophylline treatment of hyposmia and hypogeusia: a pilot study. Arch Otolaryngol Head Neck Surg. 2012 Nov;138(11):1064-70. doi: 10.1001/2013.jamaoto.342."
                },
                {
                    "pmid": "18377764",
                    "type": "RESULT",
                    "citation": "Henkin RI, Velicu I. cAMP and cGMP in nasal mucus related to severity of smell loss in patients with smell dysfunction. Clin Invest Med. 2008;31(2):E78-84. doi: 10.25011/cim.v31i2.3367."
                },
                {
                    "pmid": "19359985",
                    "type": "RESULT",
                    "citation": "Henkin RI, Velicu I, Schmidt L. An open-label controlled trial of theophylline for treatment of patients with hyposmia. Am J Med Sci. 2009 Jun;337(6):396-406. doi: 10.1097/MAJ.0b013e3181914a97."
                },
                {
                    "pmid": "21191261",
                    "type": "RESULT",
                    "citation": "Henkin RI, Velicu I, Schmidt L. Relative resistance to oral theophylline treatment in patients with hyposmia manifested by decreased secretion of nasal mucus cyclic nucleotides. Am J Med Sci. 2011 Jan;341(1):17-22. doi: 10.1097/MAJ.0b013e3181f1fdc8."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "Descriptive statistics"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000086582",
                    "term": "Anosmia"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000857",
                    "term": "Olfaction Disorders"
                },
                {
                    "id": "D000012678",
                    "term": "Sensation Disorders"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M2570",
                    "name": "Anosmia",
                    "asFound": "Hyposmia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4183",
                    "name": "Olfaction Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M15490",
                    "name": "Sensation Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}